Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Interim CEO Cornelius Becomes Permanent Chief Exec

Related Content

Bristol Aims To Be First To Market With Novel Diabetes Drug Class

Jan 11 2007

Bristol And Pfizer Team Up To Develop Anticoagulant Apixaban In $1 Billion Deal

Apr 26 2007

Bristol Director Cornelius Will Serve As Interim CEO

Sep 12 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window